Results 21 to 30 of about 47,298 (270)
Minimally invasive techniques in thymic surgery (review of literature)
Вестник хирургии имени И.И. Грекова, 2021 We carried out the systematic review of the domestic and foreign literature focusing on surgical treatment of patients with thymic pathology. Special attention was paid to the discussion of the advantages of minimally invasive surgery, particularly ...
O. V. Pikin +3 more
doaj +1 more source
Quality of life in purely ocular myasthenia in Japan [PDF]
, 2014 Background: Since there has been no conclusive evidence regarding the treatment of ocular myasthenia, treatment guidelines were recently issued by the European Federation of Neurological Societies/European Neurological Society (EFNS/ENS).
Murai, Hiroyuki +23 more
core +1 more source
Chronic mimics of myasthenia gravis: a retrospective case series
, 2023 Myasthenia gravis often presents a diagnostic challenge and may be misdiagnosed, particularly in seronegative disease with active symptoms. We retrospectively evaluated 61 patients following the introduction of single fibre electromyography at our ...
Winkel, Antony +2 more
core +1 more source
Analysis of nAChR Autoantibodies Against Extracellular Epitopes in MG Patients
Frontiers in Neurology, 2022 Myasthenia gravis (MG) is an autoimmune disorder caused by autoantibodies targeting components of the postsynaptic membrane of the neuromuscular junction (NMJ), leading to neuromuscular transmission deficiency.
Maria Michail +6 more
doaj +1 more source
Features of case management with neuromuscular disease during COVID-19. Clinical impression [PDF]
Клиническая практика, 2020 The new COVID-19 coronavirus infection, which has become a pandemic, is a very dangerous disease, the clinical picture of which can vary from mild to extremely severe forms of the course.
Olga V. Karpova +3 more
doaj +1 more source
Frontiers in NeurologyBackground and purposeMyasthenia gravis (MG) is characterized by fluctuating muscle weakness due to immune-mediated damage to acetylcholine receptors. Viral infections can exacerbate symptoms of muscle weakness, and the clinical status of patients with ...
Peng Liu +8 more
doaj +1 more source
Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
Open Medicine, 2017 Therapeutic options for thymoma-associated myasthenia gravis (MG) patients complicated with hypertension and/or diabetes post thymectomy are often conventional steroids. As the prevalence of diabetes and hypertension globally increases, other therapeutic
Qi Guoyan +4 more
doaj +1 more source
Frontiers in OncologyBackgroundImmune checkpoint inhibitors (ICI) have significantly improved the therapeutic outcomes for various malignant tumors, but they may also trigger severe immune-related adverse events (irAEs), such as myositis, myocarditis and myasthenia gravis ...
Xiaoting Lin +9 more
doaj +1 more source
Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesis
, 2021 Mice deficient for complement factors C3, C4, or C5 are resistant to experimental autoimmune myasthenia gravis (EAMG). Acetylcholine receptor (AChR) immune lymph node cells (LNC) of C3 deficient mice produce less interleukin 6 (IL-6), and EAMG-resistant ...
CHRISTADOSS, Premkumar +4 more
core +1 more source